Literature DB >> 9131639

Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity.

M R Niesman1, K A Johnson, J S Penn.   

Abstract

A newborn rat model of retinopathy of prematurity was used to test the hypothesis that a lack of superoxide dismutase contributes to the retinal vaso-attenuation seen during exposure of the animals to hyperoxic conditions. To determine the endogenous superoxide dismutase activity of the retina under hyperoxic conditions, litters of albino rats were placed in either constant 80% ambient oxygen (constant hyperoxia), or placed in 21% oxygen (room air) immediately after birth. Every other day, for 14 days, several rat pups were sacrificed and their retinas removed for the determination of total superoxide dismutase (SOD) activity and manganese-associated SOD activity. An attempt was made to increase retinal SOD activity by intraperitoneal administration of exogenous SOD encapsulated in polyethylene glycol-modified liposomes. Additional litters were exposed to the same oxygen treatments and supplemented twice daily with either liposome-encapsulated superoxide dismutase in saline or liposomes containing saline without SOD. Animals were sacrificed at various time points for the determination of total superoxide dismutase activity and computer-assisted analysis of vessel density and avascular area. Animals raised in an atmosphere of constant 80% oxygen had significantly reduced levels of retinal superoxide dismutase activity through 6 days of life when compared to their room air-raised littermates. At 6 days of age, daily supplementation with liposome-encapsulated SOD had significantly increased retinal superoxide dismutase activity and reduced oxygen-induced vaso-attenuation as evidenced by increased vessel density and decreased avascular area, when compared to littermates exposed to constant hyperoxia that received control liposomes. Superoxide dismutase had no adverse effects on any of the animals regardless of treatment. Tracing experiments demonstrated that liposomes entered the retina and were found in cells morphologically resembling microglia. Delivery of SOD to the retina via long-circulating liposomes proved beneficial, suggesting that restoration and/or supplementation of endogenous antioxidants in oxygen-damaged retinal tissue is a potentially valuable therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9131639     DOI: 10.1023/a:1022474120512

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  42 in total

1.  Twelve-hour cardiopulmonary preservation using donor core cooling, leukocyte depletion, and liposomal superoxide dismutase.

Authors:  K Bando; S Schueler; D E Cameron; P A DeValeria; M Hatanaka; A S Casale; M A Zebley; G M Hutchins; B A Reitz; W A Baumgartner
Journal:  J Heart Lung Transplant       Date:  1991 Mar-Apr       Impact factor: 10.247

2.  Protective effect of liposomal encapsulated superoxide dismutase on ischemically injured liver in the rat.

Authors:  S Senga; A Onituka; H Hirose; K Yamamoto; K Niwa
Journal:  Transplant Proc       Date:  1990-08       Impact factor: 1.066

3.  Photoconversion and electron microscopic localization of the fluorescent axon tracer fluoro-ruby (rhodamine-dextran-amine).

Authors:  L C Schmued; L F Snavely
Journal:  J Histochem Cytochem       Date:  1993-05       Impact factor: 2.479

4.  Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen injury.

Authors:  B A Freeman; S L Young; J D Crapo
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

5.  Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles.

Authors:  L D Mayer; M J Hope; P R Cullis; A S Janoff
Journal:  Biochim Biophys Acta       Date:  1985-07-11

6.  Neuronal tracing with DiI: decalcification, cryosectioning, and photoconversion for light and electron microscopic analysis.

Authors:  C S von Bartheld; D E Cunningham; E W Rubel
Journal:  J Histochem Cytochem       Date:  1990-05       Impact factor: 2.479

7.  Endocytosis-independent uptake of liposome-encapsulated superoxide dismutase prevents the killing of cultured hepatocytes by tert-butyl hydroperoxide.

Authors:  D Nakae; H Yoshiji; T Amanuma; T Kinugasa; J L Farber; Y Konishi
Journal:  Arch Biochem Biophys       Date:  1990-06       Impact factor: 4.013

8.  Augmentation of antioxidant enzymes in vascular endothelium.

Authors:  J S Beckman; R L Minor; B A Freeman
Journal:  J Free Radic Biol Med       Date:  1986

9.  Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection.

Authors:  T M Allen; C B Hansen; L S Guo
Journal:  Biochim Biophys Acta       Date:  1993-07-25

Review 10.  Free radicals in medicine. I. Chemical nature and biologic reactions.

Authors:  P A Southorn; G Powis
Journal:  Mayo Clin Proc       Date:  1988-04       Impact factor: 7.616

View more
  33 in total

Review 1.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

2.  Neonatal Intermittent Hypoxia, Reactive Oxygen Species, and Oxygen-Induced Retinopathy.

Authors:  Kay D Beharry; Charles L Cai; Gloria B Valencia; Arwin M Valencia; Douglas R Lazzaro; Fayez Bany-Mohammed; Jacob V Aranda
Journal:  React Oxyg Species (Apex)       Date:  2017-01

3.  Melatonin and amfenac modulate calcium entry, apoptosis, and oxidative stress in ARPE-19 cell culture exposed to blue light irradiation (405 nm).

Authors:  M Argun; L Tök; A C Uğuz; Ö Çelik; Ö Y Tök; M Naziroğlu
Journal:  Eye (Lond)       Date:  2014-03-07       Impact factor: 3.775

4.  NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.

Authors:  Jennifer L Wilkinson-Berka; Devy Deliyanti; Indrajeetsinh Rana; Antonia G Miller; Alex Agrotis; Roksana Armani; Cédric Szyndralewiez; Kirstin Wingler; Rhian M Touyz; Mark E Cooper; Karin A Jandeleit-Dahm; Harald H H W Schmidt
Journal:  Antioxid Redox Signal       Date:  2013-10-30       Impact factor: 8.401

5.  Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.

Authors:  Yuta Saito; Abhineet Uppal; Grace Byfield; Steven Budd; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

6.  Evaluation of lipid oxidative stress status and inflammation in atopic ocular surface disease.

Authors:  Tais H Wakamatsu; Murat Dogru; Igarashi Ayako; Yoji Takano; Yukihiro Matsumoto; Osama M A Ibrahim; Naoko Okada; Yoshiyuki Satake; Kazumi Fukagawa; Jun Shimazaki; Kazuo Tsubota; Hiroshi Fujishima
Journal:  Mol Vis       Date:  2010-11-19       Impact factor: 2.367

Review 7.  Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy.

Authors:  Elsa Kermorvant-Duchemin; Przemyslaw Sapieha; Mirna Sirinyan; Martin Beauchamp; Daniella Checchin; Pierre Hardy; Florian Sennlaub; Pierre Lachapelle; Sylvain Chemtob
Journal:  Doc Ophthalmol       Date:  2009-10-31       Impact factor: 2.379

8.  DEHP effects on retinal vessels in newborn rats: a qualitative and quantitative analysis.

Authors:  Daniela Zei; Antonia Pascarella; Chiara Barrese; Simona Pantalone; Stefania Stefanini
Journal:  Histochem Cell Biol       Date:  2009-08-23       Impact factor: 4.304

Review 9.  The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model.

Authors:  M Elizabeth Hartnett
Journal:  Doc Ophthalmol       Date:  2009-07-29       Impact factor: 2.379

10.  Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.

Authors:  Yuta Saito; Pete Geisen; Abhineet Uppal; M Elizabeth Hartnett
Journal:  Mol Vis       Date:  2007-06-12       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.